Predictive Oncology Stock Forecast - Naive Prediction

POAIDelisted Stock  USD 5.95  0.00  0.00%   
The Naive Prediction forecasted value of Predictive Oncology on the next trading day is expected to be 5.57 with a mean absolute deviation of 0.76 and the sum of the absolute errors of 46.40. Predictive Stock Forecast is based on your current time horizon. We recommend always using this module together with an analysis of Predictive Oncology's historical fundamentals, such as revenue growth or operating cash flow patterns.
  
A naive forecasting model for Predictive Oncology is a special case of the moving average forecasting where the number of periods used for smoothing is one. Therefore, the forecast of Predictive Oncology value for a given trading day is simply the observed value for the previous period. Due to the simplistic nature of the naive forecasting model, it can only be used to forecast up to one period.

Predictive Oncology Naive Prediction Price Forecast For the 26th of December

Given 90 days horizon, the Naive Prediction forecasted value of Predictive Oncology on the next trading day is expected to be 5.57 with a mean absolute deviation of 0.76, mean absolute percentage error of 1.07, and the sum of the absolute errors of 46.40.
Please note that although there have been many attempts to predict Predictive Stock prices using its time series forecasting, we generally do not recommend using it to place bets in the real market. The most commonly used models for forecasting predictions are the autoregressive models, which specify that Predictive Oncology's next future price depends linearly on its previous prices and some stochastic term (i.e., imperfectly predictable multiplier).

Predictive Oncology Stock Forecast Pattern

Backtest Predictive OncologyPredictive Oncology Price PredictionBuy or Sell Advice 

Model Predictive Factors

The below table displays some essential indicators generated by the model showing the Naive Prediction forecasting method's relative quality and the estimations of the prediction error of Predictive Oncology stock data series using in forecasting. Note that when a statistical model is used to represent Predictive Oncology stock, the representation will rarely be exact; so some information will be lost using the model to explain the process. AIC estimates the relative amount of information lost by a given model: the less information a model loses, the higher its quality.
AICAkaike Information Criteria118.178
BiasArithmetic mean of the errors None
MADMean absolute deviation0.7607
MAPEMean absolute percentage error0.0772
SAESum of the absolute errors46.4007
This model is not at all useful as a medium-long range forecasting tool of Predictive Oncology. This model is simplistic and is included partly for completeness and partly because of its simplicity. It is unlikely that you'll want to use this model directly to predict Predictive Oncology. Instead, consider using either the moving average model or the more general weighted moving average model with a higher (i.e., greater than 1) number of periods, and possibly a different set of weights.

Predictive Modules for Predictive Oncology

There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Predictive Oncology. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.
Hype
Prediction
LowEstimatedHigh
0.285.6916.36
Details
Intrinsic
Valuation
LowRealHigh
0.285.6516.32
Details
Bollinger
Band Projection (param)
LowMiddleHigh
1.559.4417.32
Details
Please note, it is not enough to conduct a financial or market analysis of a single entity such as Predictive Oncology. Your research has to be compared to or analyzed against Predictive Oncology's peers to derive any actionable benefits. When done correctly, Predictive Oncology's competitive analysis will give you plenty of quantitative and qualitative data to validate your investment decisions or develop an entirely new strategy toward taking a position in Predictive Oncology.

Predictive Oncology Related Equities

One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Predictive Oncology stock to make a market-neutral strategy. Peer analysis of Predictive Oncology could also be used in its relative valuation, which is a method of valuing Predictive Oncology by comparing valuation metrics with similar companies.
 Risk & Return  Correlation

Predictive Oncology Market Strength Events

Market strength indicators help investors to evaluate how Predictive Oncology stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Predictive Oncology shares will generate the highest return on investment. By undertsting and applying Predictive Oncology stock market strength indicators, traders can identify Predictive Oncology entry and exit signals to maximize returns.

Predictive Oncology Risk Indicators

The analysis of Predictive Oncology's basic risk indicators is one of the essential steps in accurately forecasting its future price. The process involves identifying the amount of risk involved in Predictive Oncology's investment and either accepting that risk or mitigating it. Along with some essential techniques for forecasting predictive stock prices, we also provide a set of basic risk indicators that can assist in the individual investment decision or help in hedging the risk of your existing portfolios.
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential investments, we recommend comparing similar equities with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.

Currently Active Assets on Macroaxis

Check out Your Equity Center to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation.
You can also try the Sectors module to list of equity sectors categorizing publicly traded companies based on their primary business activities.

Other Consideration for investing in Predictive Stock

If you are still planning to invest in Predictive Oncology check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Predictive Oncology's history and understand the potential risks before investing.
Technical Analysis
Check basic technical indicators and analysis based on most latest market data
Alpha Finder
Use alpha and beta coefficients to find investment opportunities after accounting for the risk
Bonds Directory
Find actively traded corporate debentures issued by US companies
Pair Correlation
Compare performance and examine fundamental relationship between any two equity instruments